Donna McNamara, MD

Dr. Donna McNamara on PARP Inhibitors for Ovarian Cancer Treatment

January 20th 2015

Donna McNamara, MD, Co-Chief of the Gynecologic Oncology Division and Medical Oncologist for the Breast Oncology Division at the John Theurer Cancer Center, talks about the benefits of PARP inhibitors for women with BRCA1 or BRCA2-mutated, platinum-sensitive ovarian cancer.